Status:
COMPLETED
Parkin Mutations and Their Functional Consequences
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Parkinson's disease (PD) is the most frequent neurodegenerative disease with a prevalence of 2% over 65 years and because of this high prevalence as the population ages, it is a major problem of publi...
Eligibility Criteria
Inclusion
- Patients presenting with Parkinson's disease, with a family history or not,
- Minors presenting clinical signs of the disease,
- Controls (without signs of the disease, matched by sex and age with the patients, relatives for the familial cases)
Exclusion
- Persons refusing to sign the informed consent,
- Lack of clinical information
Key Trial Info
Start Date :
February 8 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2021
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00136721
Start Date
February 8 2005
End Date
February 7 2021
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pitié-Salpêtrière
Paris, France, 75013